Prospective Study of the Impact of Systemic Corticosteroid Use on Measures of Sleep Disordered Breathing
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01228695|
Recruitment Status : Completed
First Posted : October 26, 2010
Last Update Posted : October 26, 2010
Weight gain is both a significant risk factor for obstructive sleep apnea and a side-effect of long-term systemic steroids therapy.
This study aimed to investigate the impact of long-term systemic steroid treatment on sleep apnea.
|Condition or disease||Intervention/treatment|
|Sleep Apnea||Other: sleep study|
|Study Type :||Observational|
|Enrollment :||20 participants|
|Study Start Date :||January 2007|
|Actual Primary Completion Date :||January 2010|
|Actual Study Completion Date :||January 2010|
Other: sleep study
The polysomnography (PSG) (Alice 3 System; Healthdyne, Atlanta, GA) consisted of continuous polygraphic recording from surface leads for electroencephalography, electrooculography, electromyography, electrocardiography, thermistors for nasal and oral airflow, thoracic and abdominal impedance belts for respiratory effort, pulse oximeter for oxyhemoglobin level, tracheal microphone for snoring, and sensors for leg and sleep position
Other Name: no other names
- apnea-hypopnea index [ Time Frame: 3 months ]
- sleep study variables [ Time Frame: 3 months ]apnea-hypopnea interval desaturation at the end of apnea interval snoring intensity
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01228695
|Rambam health care campus|
|Haifa, Israel, 31096|